Osteochondral Lesions of the Talus (OCD)

What is an osteochondral lesion of the talus?

An osteochondral lesion of the talus (OLT), also called a talar dome lesion or osteochondral defect (OCD), affects the cartilage covering the talar dome and often the bone immediately beneath it. These injuries can follow an ankle sprain or fracture, or develop without a remembered major injury. An OLT is a focal defect, not necessarily widespread ankle arthritis. Some lesions are painless incidental findings; treatment is based on symptoms, stability and lesion characteristics rather than the MRI report alone.

Symptoms

Patients may report deep ankle pain, swelling with activity, stiffness, catching or difficulty returning to sport. Locking is less common and may suggest an unstable fragment or loose body. Associated lateral ankle ligament instability may contribute to symptoms and influence treatment results.

Diagnosis

Weight-bearing X-rays are a useful starting point but may miss smaller lesions. MRI helps show cartilage condition, marrow oedema and associated soft-tissue injury. CT is particularly helpful for defining subchondral bone, cysts, fragments and bony architecture; sometimes both MRI and CT are useful. Arthroscopy allows direct inspection of the cartilage surface when surgery is performed and may reveal damage not fully characterised by imaging.

Treatment without surgery

Selected stable lesions, especially with tolerable symptoms, may be managed with activity modification, physiotherapy, temporary protection or immobilisation in appropriate cases, and treatment of associated instability. Persistent pain, an unstable fragment, sizable bone loss or failure of a reasonable trial of non-operative treatment may prompt a discussion of surgery.

Choosing an operation

There is no single best operation for all OLTs. Critical factors include defect area, depth, the integrity of the overlying cartilage, the presence of a viable bone-containing fragment, cystic bone loss, previous procedures, location and surrounding joint health. Treatment recommendations below are general frameworks, not a rigid size-only algorithm.

Arthroscopic debridement and microfracture (bone marrow stimulation)

Unstable cartilage is removed, the defect is prepared, and small holes are made in the subchondral bone to allow marrow elements to enter and form repair tissue. This is a well-established option for carefully selected small, contained defects without substantial bone loss. Current European guidance supports this mainly for lesions smaller than about 1 cm² (about 1 cm by 1 cm) without a bony defect; for larger lesions, adding a supporting scaffold is recommended. The resulting repair tissue is predominantly fibrocartilage rather than normal hyaline cartilage, and larger or deeper lesions have less predictable durability. Microdrilling is a related marrow-stimulation technique; no single method is clearly superior for every patient.

AutoCart (autologous minced-cartilage implantation)

AutoCart is a minced-cartilage technique: loose or damaged cartilage from the lesion is collected arthroscopically, finely minced and returned to the prepared defect, where it is sealed with a fibrin glue made from the patient’s own blood. Additional bone grafting may be necessary when the underlying bone is deficient. It is a single-stage biological approach, but it has not been shown to regenerate normal cartilage or to work better than microfracture. Evidence in the ankle is still very limited. The 2024 European guideline found no supporting data for minced cartilage, and the main study since then (2025) followed 29 patients for one year without a comparison group. Function improved, but the average reduction in pain was small, and most patients also had bone grafting through a cut in the inner ankle bone (26 of 29) or a ligament reconstruction (16 of 29) at the same operation, so the benefit of the minced cartilage itself is unclear. Longer-term comparative studies are needed.

Fixation of an osteochondral fragment

When a detached or unstable fragment contains enough viable cartilage and underlying bone to restore the surface, it may be possible to reduce and fix it with small implants. This preserves the native joint surface when union succeeds. Large, suitable fragments are more likely to be considered than thin cartilage-only pieces. For selected chronic lesions, a ‘lift, drill, fill and fix’ (LDFF) approach may include preparation and bone grafting under the fragment before fixation. Risks include nonunion, residual pain and fixation failure.

Retrograde drilling (without grafting)

Retrograde drilling approaches the subchondral bone from beneath an intact cartilage surface rather than making holes through it. It may be considered for selected early subchondral lesions with intact cartilage and no significant cystic bone defect. This technique has limited clinical evidence: the 2024 European guideline notes that it appears to work better in children with open growth plates than in adults, yet even in children revision rates of up to 50% have been reported. It is not a routine first-choice treatment for an OLT.

Retrograde cyst treatment and bone grafting

A separate technique can access a subchondral cyst from below, remove or decompress abnormal material and fill the defect with cancellous graft or selected bone substitute while trying to preserve intact overlying cartilage. This is not the same as drilling alone. It is suited only to appropriately selected lesions and carries uncertainty about whether the cartilage is truly intact and whether all cyst material can be cleared. Evidence is limited.

Osteochondral grafting and scaffold-assisted repair

Larger defects, substantial bone loss or failed previous surgery may require osteochondral autograft or allograft transplantation, or a scaffold-assisted method such as matrix-assisted bone marrow stimulation. Osteochondral autograft provides a cartilage-and-bone plug but creates a donor site, often at the knee. Reviews report good or excellent results in most patients (around 87%), although knee problems at the donor site occur in up to about 17%. Allografts avoid patient donor-site harvesting but bring graft-related considerations. Scaffolds and biologic additions are not all supported equally by evidence. Not every option suits every lesion; Mr Senthi will discuss the ones relevant to you.

Procedure selection at a glance

Small, contained defect without substantial bone loss: often consider arthroscopic debridement and bone marrow stimulation.
Large viable cartilage-and-bone fragment: consider native-fragment fixation where technically feasible.
Intact cartilage with limited subchondral disease and no significant cyst: retrograde drilling may be considered selectively, with evidence limitations explained.
Intact cartilage above a symptomatic cyst: selected retrograde cyst treatment and bone grafting rather than drilling alone.
Selected larger cartilage defects (over about 1 cm²): scaffold-assisted repair, or newer options such as minced cartilage (AutoCart), may be discussed; evidence for minced cartilage is still early.
Large, deep or revision lesions: consider osteochondral transplantation or another reconstructive approach after detailed imaging and examination.

Associated problems

Ankle instability, deformity or impingement may need simultaneous or staged management. Persistent instability can place abnormal stress on the repair and worsen outcomes. A repair cannot guarantee the avoidance of future arthritis or the restoration of normal cartilage.

Recovery

Rehabilitation varies markedly across techniques. Simple debridement, microfracture, cartilage implantation, fixation and bone grafting do not share one weight-bearing protocol. Cartilage and bone repairs often need a period of protection and staged return to impact activity over months. As a general guide, after arthroscopic microfracture many people use crutches with limited weight-bearing for 2–6 weeks; when a bone cut (malleolar osteotomy) or bone graft is needed, protection is usually about 6 weeks. Return to running commonly takes 4–6 months. Further surgery may be required for persistent symptoms, fragment nonunion or repair failure. Contact the rooms promptly if you develop a fever, increasing wound redness or discharge, severe worsening pain or calf swelling after surgery; call 111 for chest pain or breathlessness.

Risks

Potential problems include infection, nerve injury, postoperative stiffness, persistent pain or swelling, blood clots, incomplete repair, graft/fixation failure, progression of joint degeneration and further surgery. The risk profile changes when a malleolar osteotomy, bone graft or ligament reconstruction is added.

Common questions

Is an OLT the same as ankle arthritis?
No. An OLT is typically focal, whereas ankle osteoarthritis generally involves more widespread joint change; they can coexist.

Is microfracture suitable for every lesion?
No. Results are generally most reliable in small, contained defects without major bone loss.

Is AutoCart proven better?
No. Early results are encouraging but come from small studies without comparison groups; long-term evidence is lacking.

Can the original fragment be saved?
Sometimes, if it has a sufficiently substantial, viable bone component and can be stably fixed.

Is retrograde drilling the same as bone grafting a cyst?
No. These are related but distinct procedures with different indications.

Seeking specialist advice

Persistent deep ankle symptoms after an injury, especially with swelling or catching, may warrant evaluation. Decisions about OLT treatment should be individualised with clinical findings and MRI/CT morphology. If the lesion followed an ankle injury, ACC may cover part of the cost; see the ACC questions on our Your appointment page.

Book an appointment